Vaxart, Inc.: Form 10-Q for the period ended Jun 30, 2022
Filed with the SEC on Aug 8, 2022 and accepted by EDGAR at Aug 8, 2022, 17:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $0 | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2022-01-01 to 2022-06-30 | $85.0k | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Research and development | 3 months2022-04-01 to 2022-06-30 | $19.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-01-01 to 2022-06-30 | $38.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-04-01 to 2022-06-30 | −$29.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-01-01 to 2022-06-30 | −$54.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-04-01 to 2022-06-30 | $15.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-06-30 | $35.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | −$29.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-06-30 | −$54.5m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2022-04-01 to 2022-06-30 | −$0.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-01-01 to 2022-06-30 | −$0.43 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months2022-01-01 to 2022-06-30 | −$51.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-01-01 to 2022-06-30 | $3.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2022-06-30 | $137.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-06-30 | $181.5m | us-gaap:Assets |
| Current liabilities | At period end2022-06-30 | $15.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-06-30 | $38.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-06-30 | $143.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-22-019415. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.